Making genuine progress against metastatic breast cancer.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 30, Issue 28, p.3448-51 (2012)

Keywords:

Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Breast Neoplasms, Disease-Free Survival, Drug Approval, Endpoint Determination, Female, Humans, Neoplasm Metastasis, Survival Rate, United States, United States Food and Drug Administration